US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
USOTC
PharmaTher Holdings Ltd (QB) (PHRRF)
PharmaTher Holdings Ltd (QB) (PHRRF) ニュース

PHRRF

PharmaTher (QB) (PHRRF)

PharmaTher Holdings Ltd (QB)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:PHRRF

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/09/19	19 : 31	TipRanks	Analysts Offer Insights on Healthcare Companies: PharmaTher Holdings Ltd (OtherPHRRF), Rezolute (RZLT) and ADC Therapeutics (ADCT)	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2022/06/15	18 : 03	TipRanks	H.C. Wainwright Keeps a Buy Rating on PharmaTher Holdings Ltd (PHRRF)	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/11/22	20 : 16	TipRanks	H.C. Wainwright Thinks NPharmaTher’s Stock is Going to Recover	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/11/12	00 : 00	InvestorsHub NewsWire	PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/11/03	21 : 03	InvestorsHub NewsWire	PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/10/19	20 : 07	InvestorsHub NewsWire	PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/10/13	22 : 20	InvestorsHub NewsWire	PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/09/21	23 : 19	InvestorsHub NewsWire	PharmaTher Added to the North American Psychedelics Index and First Psychedelic Exchange Traded Fund	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/09/13	22 : 03	InvestorsHub NewsWire	PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/08/04	21 : 15	InvestorsHub NewsWire	PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/07/21	21 : 19	InvestorsHub NewsWire	PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/06/17	00 : 14	InvestorsHub NewsWire	PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/05/25	21 : 45	InvestorsHub NewsWire	PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig's Disease	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/05/17	21 : 02	InvestorsHub NewsWire	PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson's Disease	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/04/27	20 : 47	InvestorsHub NewsWire	PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for Ketamine and Repurposing of Psychedelics..Cont	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/04/20	21 : 00	InvestorsHub NewsWire	PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/04/16	00 : 32	InvestorsHub NewsWire	PharmaTher Provides Update on Psychedelic Product Programs	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/03/02	21 : 34	InvestorsHub NewsWire	PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou....Cont	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/02/18	00 : 11	InvestorsHub NewsWire	PharmaTher Announces Sale of Psilocybin Program	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/02/04	22 : 21	InvestorsHub NewsWire	PharmaTher Announces Successful Completion of Pre-IND Meeting with FDA	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/02/01	22 : 19	InvestorsHub NewsWire	PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)
2021/01/19	22 : 07	InvestorsHub NewsWire	PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation	USOTC:PHRRF	PharmaTher Holdings Ltd (QB)

Showing the most relevant articles for your search:USOTC:PHRRF

1

Neoenergia (PK)

Napatech AS (GM)

Colombier Acquisition

BNP Paribas Issuance

Societe Generale Effekten

Wt At1coco Usdh

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約